| abstract |
Described herein are calcitonin mimetics that are acylated at a lysine residue located at position 11 or 19 of the calcitonin mimetic, and their use as medicaments in the treatment of various diseases and disorders, including diabetes. , excess body weight, excessive food consumption and metabolic syndrome, NASH, alcoholic and nonalcoholic fatty liver disease, regulation of blood glucose levels, regulation of response to tolerance tests to glucose, the regulation of food intake, and the treatment of osteoporosis and the treatment of osteoarthritis. |